PrepAway - Latest Free Exam Questions & Answers

which of the following is the best answer?

Scenario MedInc Products Ltd. Please read this scenario prior to answering the Question.
MedInc Products Ltd. is a leading medical device manufacturer in the highly competitive
market for Migraine Headache Pain Management (MHPM) devices. These tiny wireless
devices are implanted in the brain and can deliver a precise electric shock when the
wearable Pain Control Unit (PCU) detects an increase in stress induced by the onset of a

migraine headache. This technology will be a breakthrough in the treatment of this
condition, and several competitors are striving to be the first to introduce a product into the
market. However, all of them must demonstrate the effectiveness and safety of their
products in a set of clinical trials that will satisfy the regulatory requirements of the countries
in the target markets. The Enterprise Architecture group at MedInc Products has been
engaged in an architecture development project to create a secure networked collaboration
system that will allow researchers at its product development laboratories worldwide to
share information about their independent clinical trials. The Enterprise Architecture group is
a mature organization that has been utilizing TOGAF for several years. The MedInc
Architecture Development Method is strictly based on TOGAF 9 with extensions required to
support current good manufacturing practices and good laboratory practices in their target
markets. The project team has now completed the Business, Information Systems, and
Technology Architecture phases and has produced a complete set of deliverables for each
phase. Due to the highly sensitive nature of the information that is managed, special care
was taken to ensure that each architecture domain included an examination of the security
and privacy issues that are relevant for each domain. A corresponding Security Architecture
has been defined. The Executive Vice President for Clinical Research is the sponsor of the
Enterprise Architecture activity. He has stated that the changes to the enterprise
architecture for the new system will need to be rolled out on a geographic basis that will
minimize disruptions to ongoing clinical trials. The work will need to be done in stages and
rolled out in geographical regions. Refer to the Medlnc Products Ltd. Scenario You are
serving as the Lead Architect for the project team. You have been asked to recommend the
approach to identify the work packages that will be included in the Transition
Architecture(s). Based on TOGAF 9, which of the following is the best answer?

PrepAway - Latest Free Exam Questions & Answers

A.
Create an Implementation Factor Assessment and Deduction Matrix and a Consolidated
Gaps, Solutions and Dependencies Matrix. For each gap, identify a proposed solution and
classify it as new development, purchased solution, or based on an existing product. Group
similar solutions together to form work packages. Identify dependencies between work
packages factoring in the clinical trial schedules. Regroup the packages into a set of
Capability Increments scheduled into a series of Transition Architectures and documented
in an Architecture Definition Increments Table.

B.
Determine the set of Solution Building Blocks required by identifying which Solution

Building Blocks need to be developed and which need to be procured. Eliminate any
duplicate building blocks. Group the remaining Solution Building Blocks together to create
the work packages using a CRUD matrix. Rank the work packages in terms of cost and
select the most cost-effective options for inclusion in a series of Transition Architectures.
Schedule the roll out of the work packages to be sequential across the geographic regions.

C.
Use a Consolidated Gaps, Solutions and Dependencies Matrix as a planning tool. For
each gap classify whether the solution is either a new development, purchased solution, or
based on an existing product. Group the similar solutions together to define the work
packages. Regroup the work packages into a set of Capability Increments to transition to
the Target Architecture taking into account the schedule for clinical trials.

D.
Group the Solution Building Blocks from a Consolidated Gaps, Solutions and
Dependencies Matrix into a set of work packages. Using the matrix as a planning tool,
regroup the work packages to account for dependencies. Sequence the work packages into
the Capability Increments needed to achieve the Target Architecture. Schedule the rollout
one region at a time. Document the progression of the enterprise architecture using an
Enterprise Architecture State Evolution table.

3 Comments on “which of the following is the best answer?

  1. ashg says:

    A – “Group similar solutions together to form work packages” seems incorrect hence not correct answer for me.
    B – Following eliminates, for me, B as correct answer
    “Eliminate any duplicate building blocks” – no reference in TOGAF of such activity. did i miss something ?
    CRUD matrix showing which applications Create, Read, Update, and Delete a
    particular type of data
    C – “Group similar solutions together to form work packages” seems incorrect hence not correct answer for me.

    D seems appropriate for following reasons
    regroup the work packages to account for “dependencies”
    Schedule the rollout one region at a time
    -Enterprise Architecture State Evolution table.




    0



    0

Leave a Reply

Your email address will not be published. Required fields are marked *